<DOC>
	<DOCNO>NCT02171793</DOCNO>
	<brief_summary>Study investigate safety , tolerability , pharmacokinetics single rise peroral dos BI 1744 CL .</brief_summary>
	<brief_title>Single Rising Peroral Doses BI 1744 CL Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Olodaterol</mesh_term>
	<criteria>Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test Age ≥21 ≤45 year BMI ≥18.5 &lt; 30 kg/m2 ( Body Mass Index ) Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation Any finding medical examination ( include BP , PR , ECG measurement ) deviate normal clinical relevance Evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History relevant allergy/hypersensitivity ( include allergy drug excipients ) judge clinically relevant investigator Intake drug long halflife ( &gt; 24 hour ) within least 1 month less 10 halflives respective drug prior randomisation Use drug might reasonably influence result trial base knowledge time protocol preparation within 10 day prior enrolment study study Participation another trial investigational drug within 30 day prior randomisation Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day judge investigator Alcohol abuse ( regularly 40 g alcohol per day ) Drug abuse Blood donation ( 100 mL blood within 4 week prior randomisation trial ) Excessive physical activity within 1 week prior randomisation trial Any laboratory value outside reference range clinical relevance Inability comply dietary regimen study centre The following exclusion criterion specific study due know class side effect profile β2 mimetic drug : Asthma history pulmonary hyperreactivity Hyperthyrosis Allergic rhinitis need treatment Clinically relevant cardiac arrhythmia Paroxysmal tachycardia ( &gt; 100 beat per minute )</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>